1. World Health Organization (2015). Global Action Plan on Antimicrobial Resistance, World Health Organization.
2. Dittrich, S., Tadesse, B.T., Moussy, F., Chua, A., Zorzet, A., Tängdén, T., Dolinger, D.L., Page, A., Crump, J.A., and D’Acremont, V. (2016). Target product profile for a diagnostic assay to differentiate between bacterial and non-bacterial infections and reduce antimicrobial overuse in resource-limited settings: An expert consensus. PLoS ONE, 11.
3. Dittrich, S. (2015). Meeting of Experts on Biomarkers to Discriminate Bacterial from Other Infectious Causes of Acute Fever, World Health Organization.
4. National Research Council (US) Committee on New Directions in the Study of Antimicrobial Therapeutics: New Classes of Antimicrobials, and National Research Council (US) Committee on New Directions in the Study of Antimicrobial Therapeutics: Immunomodulation (2006). Treating Infectious Diseases in a Microbial World: Report of Two Workshops on Novel Antimicrobial Therapeutics, The National Academies Press (US).
5. Antibiotic resistance in ICUs: A multifaceted problem requiring a multifaceted solution;Gaynes;Infect. Control Hosp. Epidemiol.,1995